Search  in | Advanced
   Print  
Blood Products Advisory Committee

  
In This Section:
Resources

Quick Links:
FDA/CBER Blood Products Advisory Committee

FDA/CBER Meeting Resources
  

The Blood Products Advisory Committee advises the FDA commissioner on issues that help ensure safe and effective biological products and related medical devices. Members of the committee — which include authorities knowledgeable in the fields of medicine, hematology, blood banking, and other related professions — review and evaluate available data on blood products intended for use in the diagnosis, prevention or treatment of human diseases and make recommendations about labeling, clinical and laboratory studies, approval or revocation of licenses, and on the quality and relevance of FDA’s research program, which provides the scientific support for regulating these products.

This section includes information on current and past committee meetings, including meeting summaries, resources and analysis as well as quick links to other relevant materials.

BPAC Meeting - 9/10-9/11/08
BPAC Meeting - 8/16/07

BPAC Meeting - 4/26-4/27/07

BPAC Meeting - 12/14/06

Last modified on 11/6/2008 12:55:40 PM
What's New!
AABB Weekly Report - December 19, 2008
Details
AABB Patient and Donor Safety Center Named a Patient Safety Organization by Department of Health and Human Services
Details
The Proposed 4th edition of Standards for Perioperative Autologous Blood Collection and Administration
Details
The Proposed 26th edition of Standards for Blood Banks and Transfusion Services
Details
CMS Publishes 2009 Hospital Outpatient Prospective Payment System Rule
Details
FDA Liaison Meeting Summary
Details
2007 National Blood Collection and Utilization Survey
Details
Call for AABB Award Nominations
Details
Association Bulletin #08-04 - Strategies to Reduce Adverse Reactions and Injuries in Younger Donors
Details
First Ever National Biovigilance Network in the U.S. Reaches $1 Million in Funding, Prepares for Fall Pilot Launch
Details
List of AABB-Accredited Facilities with Approved Variances for ISBT 128
Details